ConductScience.org, home

Paper40434646

Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling.

Ota N and 24 others. Proc Natl Acad Sci U S A, 2025. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling. Papers, record 40434646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40434646

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
2.62, provisional
iCite
Revised in PubMed
2025-11-29
PubMed

Authors25

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ota NNaruhisahttps://orcid.org/0000-0001-6663-7336
2Davies CWChristopher Whttps://orcid.org/0000-0001-9559-438X
3Kang JJing
4Yan DDonghonghttps://orcid.org/0000-0001-7686-2756
5Scherl AAlexishttps://orcid.org/0000-0001-6130-3118
6Wong AAnnehttps://orcid.org/0009-0005-7308-7375
7Cook RRyan
8Tao XXunhttps://orcid.org/0009-0004-5477-3786
9Dunlap DDebra
10Klabunde SSha
11Mantik PPriscilla
12Mohanan VVishnu
13Lin WWeiYuhttps://orcid.org/0000-0003-4363-7848
14McBride JJacqueline
15Sadekar SShraddha
16Storek KMKelly Mhttps://orcid.org/0000-0002-2289-0214
17Lupardus PPatrick
18Ye ZZhengmao
19Ackerly Wallweber HHeidi
20Kiefer JRJames Rhttps://orcid.org/0000-0001-6317-0902

Source PubMed

See all 25 authorsDownload CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interleukin-23Major topic
Single-Domain AntibodiesMajor topic
Signal TransductionMajor topic
Peptide HydrolasesMajor topic
Animals
Mice
Humans
Administration, Oral
Protein Engineering
Colitis
Inflammatory Bowel Diseases

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 GM124165NIGMS NIH HHSUnited StatesP30GM124165PubMed and NIHNIH RePORTER
P30 GM124169NIGMS NIH HHSUnited StatesP30GM124169PubMed and NIHNIH RePORTER
S10 OD021832NIH HHSUnited StatesS10OD021832PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in40802696Correction for Ota et al., Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling.https://conductscience.org/library/papers/40802696

Source PubMed

Download CSV of comments and corrections

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134460338A non-clinical comparative study of IL-23 antibodies in psoriasis.MAbs2021https://conductscience.org/library/papers/34460338PubMed
221460454REFMAC5 for the refinement of macromolecular crystal structures.Acta Crystallogr D Biol Crystallogr2011https://conductscience.org/library/papers/21460454PubMed
323915679Gastrointestinal transit measurements in mice with 99mTc-DTPA-labeled activated charcoal using NanoSPECT-CT.EJNMMI Res2013https://conductscience.org/library/papers/23915679PubMed
427754618Processing of X-ray diffraction data collected in oscillation mode.Methods Enzymol1997https://conductscience.org/library/papers/27754618PubMed
529569425Comparative analysis of nanobody sequence and structure data.Proteins2018https://conductscience.org/library/papers/29569425PubMed
629287995Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12Rβ1.Immunity2018https://conductscience.org/library/papers/29287995PubMed
738438014Colitis-Induced Small Intestinal Hypomotility Is Dependent on Enteroendocrine Cell Loss in Mice.Cell Mol Gastroenterol Hepatol2024https://conductscience.org/library/papers/38438014PubMed
820124692XDS.Acta Crystallogr D Biol Crystallogr2010https://conductscience.org/library/papers/20124692PubMed
928057863Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28057863PubMed
1038936360Preclinical proof of principle for orally delivered Th17 antagonist miniproteins.Cell2024https://conductscience.org/library/papers/38936360PubMed
1117068223A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.Science2006https://conductscience.org/library/papers/17068223PubMed
1223406896Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human.MAbs2013https://conductscience.org/library/papers/23406896PubMed
1337468638Mega-scale experimental analysis of protein folding stability in biology and design.Nature2023https://conductscience.org/library/papers/37468638PubMed
1428325875Ab initio solution of macromolecular crystal structures without direct methods.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28325875PubMed
1531575982Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients.Sci Rep2019https://conductscience.org/library/papers/31575982PubMed
1616919486Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology.Immunity2006https://conductscience.org/library/papers/16919486PubMed
171560463Antibody framework residues affecting the conformation of the hypervariable loops.J Mol Biol1992https://conductscience.org/library/papers/1560463PubMed
1837003258Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut.Cell Host Microbe2023https://conductscience.org/library/papers/37003258PubMed
1926896086Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease.J Crohns Colitis2016https://conductscience.org/library/papers/26896086PubMed
202052525Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects.Pharm Res1991https://conductscience.org/library/papers/2052525PubMed

See all 46 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42723759Narrative review of research progress and future development of bispecific antibodies in lung cancer: opportunities and challenges.Transl Lung Cancer Res2026https://conductscience.org/library/papers/42723759PubMed
41880566A modular platform for Sterically Masked Activated Cytokines (SMACks).Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/41880566PubMed
41745409Interleukin-23p19 Inhibitors in Inflammatory Bowel Disease: From Current Insights to Future Directions.J Pers Med2026https://conductscience.org/library/papers/41745409PubMed
41675494Deciphering the immunocellular regulatory network in inflammatory bowel disease: from susceptibility genes to cellular effectors and toward precision therapies.Front Immunol2025https://conductscience.org/library/papers/41675494PubMed
41524227Antibody-Empowered Nanomedicine for Precise Biomedical Applications.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41524227PubMed
41421354Engineered probiotics platform for oral delivery of antibody as a high-compliance alternative for immune-mediated inflammatory diseases.Cell Rep Med2026https://conductscience.org/library/papers/41421354PubMed
41193399From discovery to the clinic: structural insights, engineering options, clinical, and 'next wave' applications of camelid-derived single-domain antibodies.MAbs2025https://conductscience.org/library/papers/41193399PubMed
40775487Fifty years of monoclonals: the past, present and future of antibody therapeutics.Nat Rev Immunol2025https://conductscience.org/library/papers/40775487PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40434646

GET https://conductscience.org/api/papers/v1/40434646/authors?page=2